Format

Send to

Choose Destination

See 1 citation found by title matching your search:

J Invest Dermatol. 2017 Apr;137(4):941-950. doi: 10.1016/j.jid.2016.11.035. Epub 2016 Dec 23.

Dermal Fibroblasts Promote Alternative Macrophage Activation Improving Impaired Wound Healing.

Author information

1
Department of Dermatology, Allergology and Venerology, Leipzig University Medical Center, Leipzig, Germany.
2
Department of Dermatology, Allergology and Venerology, Leipzig University Medical Center, Leipzig, Germany; Transregio Collaborative Research Centre TRR67, German Research Foundation (Deutsche Forschungsgemeinschaft), University Leipzig and Technical University Dresden, Leipzig, Germany.
3
Department of Dermatology, Allergology and Venerology, Leipzig University Medical Center, Leipzig, Germany; Transregio Collaborative Research Centre TRR67, German Research Foundation (Deutsche Forschungsgemeinschaft), University Leipzig and Technical University Dresden, Leipzig, Germany. Electronic address: sandra.franz@medizin.uni-leipzig.de.

Abstract

Tight control of inflammation is required for tissue repair and wound healing and depends on alternative polarization of macrophages as checkpoint for inflammatory resolution. Its perturbations lead to impaired regeneration. Administration of cells/cell factors capable of reversing inflammation and rescuing alternative polarization could be promising for treating inflammatory diseases. We show that human dermal fibroblasts (dFb) are ideal candidates for such a task by demonstrating a new function of these cells, which is modulating macrophage polarization. Coculture of dFb with human monocytes in vitro or injection of dFb into mice with thioglycollate-induced peritonitis favors alternative macrophage activation and reduces inflammation by releasing tumor necrosis factor-inducible gene 6 protein and Cox-2 products. Silencing these factors in dFb abolishes the reported effects, demonstrating their importance for immunomodulation. Importantly, in a model of delayed wound healing due to prolonged inflammation (db/db mice), administration of dFb improves defective tissue repair with augmentation of alternative macrophage polarization and inflammation resolution. Human dFb are low immunogenic cells, easy to obtain, and can be expanded extensively in vitro conserving their immunomodulatory capacity; this, together with our findings, suggests that dFb might represent an alternative for cell-based therapies of conditions characterized by excessive inflammation and delayed tissue repair.

PMID:
28017830
DOI:
10.1016/j.jid.2016.11.035
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center